David L. Vesely
- Cardiology and Cardiovascular Medicine top 1%
- Molecular Biology top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Co-authors
- A. KalendováWilliam R. GowerChris J. WintersAlan L. SallmanJaroslav StejskalPetr KalendaGerald S. LeveyDouglas D. Schocken
- Topics
- Heart Failure Treatment and Management (67 papers)Pigment Synthesis and Properties (19 papers)PI3K/AKT/mTOR signaling in cancer (18 papers)
- Partner nations
- United StatesCzechiaRussia
In The Last Decade
David L. Vesely
296 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 166
- Cardiology and Cardiovascular Medicine 2.1k
- Molecular Biology 1.6k
- Oncology 834
- Pulmonary and Respiratory Medicine 714
- Endocrinology, Diabetes and Metabolism 635
Countries citing papers authored by David L. Vesely
This map shows the geographic impact of David L. Vesely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Vesely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Vesely more than expected).
Fields of papers citing papers by David L. Vesely
This network shows the impact of papers produced by David L. Vesely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Vesely. The network helps show where David L. Vesely may publish in the future.
Co-authorship network of co-authors of David L. Vesely
This figure shows the co-authorship network connecting the top 25 collaborators of David L. Vesely. A scholar is included among the top collaborators of David L. Vesely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Vesely. David L. Vesely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Family of peptides synthesized in the human body have anticancer effects. | 10 |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 14 | |
| 5 | 42 | |
| 6 | 33 | |
| 7 | 36 | |
| 8 | 3 | |
| 9 | 11 | |
| 10 | 7 | |
| 11 | 5 | |
| 12 | 11 | |
| 13 | 35 | |
| 14 | 10 | |
| 15 | 37 | |
| 16 | 29 | |
| 17 | 64 | |
| 18 | 21 | |
| 19 | 110 | |
| 20 | Activation of guanylate cyclase by streptozotocin and 1-methyl-1-nitrosourea. | 42 |
About David L. Vesely
David L. Vesely is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 302 papers that have together received 5.9k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (67 papers), Pigment Synthesis and Properties (19 papers) and PI3K/AKT/mTOR signaling in cancer (18 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.1k citations), Endocrinology, Diabetes and Metabolism (635 citations) and Bioengineering (205 citations). David L. Vesely has collaborated with scholars based in United States, Czechia and Russia. Frequent co-authors include A. Kalendová, William R. Gower, Chris J. Winters, Alan L. Sallman, Jaroslav Stejskal, Petr Kalenda, Gerald S. Levey, Douglas D. Schocken, David M. Rico and John R. Dietz. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.